Current drug treatment for tuberculosis (TB) does not eliminate Mycobacterium tuberculosis from the body, which means that
the infection can reactivate in the future. Now, findings from Korean investigators,
published February 3 in an online edition of Gene Therapy (http://www.nature.com/gt /index.html), suggest that combining standard
TB drug therapy with a vaccine containing M tuberculosis DNA might offer a way to clear the body of the infection relatively
quickly and guard against repeat infection.
Stephenson J. New TB Strategy. JAMA. 2005;293(11):1316. doi:10.1001/jama.293.11.1316-c